- 专利标题: Heteronucleic acid containing scpBNA or AmNA
-
申请号: US18563128申请日: 2022-05-24
-
公开(公告)号: US20240240183A1公开(公告)日: 2024-07-18
- 发明人: Takanori YOKOTA , Tetsuya NAGATA , Kotaro YOSHIOKA , Satoshi OBIKA
- 申请人: NATIONAL UNIVERSITY CORPORATION TOKYO MEDICAL AND DENTAL UNIVERSITY , OSAKA UNIVERSITY
- 申请人地址: JP Tokyo
- 专利权人: NATIONAL UNIVERSITY CORPORATION TOKYO MEDICAL AND DENTAL UNIVERSITY,OSAKA UNIVERSITY
- 当前专利权人: NATIONAL UNIVERSITY CORPORATION TOKYO MEDICAL AND DENTAL UNIVERSITY,OSAKA UNIVERSITY
- 当前专利权人地址: JP Tokyo; JP Osaka
- 优先权: JP 21087941 2021.05.25
- 国际申请: PCT/JP2022/021251 2022.05.24
- 进入国家日期: 2023-11-21
- 主分类号: C12N15/113
- IPC分类号: C12N15/113 ; A61K9/00 ; A61P29/00 ; A61P37/06
摘要:
A problem to be solved by the present invention is to provide a double-stranded nucleic acid complex having a reduced toxicity whose effectiveness is not impaired. Provided is a double-stranded nucleic acid complex comprising a first nucleic acid strand and a second nucleic acid strand, wherein: said first nucleic acid strand is capable of hybridizing to at least part of a target gene or a transcription product thereof, and has an antisense effect on said target gene or transcription product thereof, said second nucleic acid strand comprises a base sequence complementary to said first nucleic acid strand, and said first nucleic acid strand and/or said second nucleic acid strand comprises at least one bridged non-natural nucleoside represented by formula (I) or formula (II) (wherein R represents a hydrogen atom or a methyl group).
信息查询
IPC分类: